Brind.

ABR reflected analyst recommendations for Eli Lilly and Company.

2 reports, 1 independent Updated Jul 18

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

ABR reflected analyst recommendations for Eli Lilly and Company.

Who's involved

What this event is mainly about

ABR Eli Lilly and Company

Keep exploring

The entities involved

ABR
Czech company
- W.P. Carey holds a large portfolio in the United States and Western Europe, with top 10 tenants accounting for 19.4% of ABR.Sun 05:51
- ABR is calculated based on analyst recommendations, using Zacks Rank to categorize stocks for price performance.Sun 04:48
Eli Lilly and Company
American pharmaceutical company
- ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
- The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Related events

A senior research scientist from Eli Lilly and Company is presenting abstracts at the AAIC conference in London.Jul 9
Soutrik Banerjee is currently employed as a consultant at Eli Lilly and Company.Sep 11
ABR is mentioned as a competitor to Realty Income in the income investment space.Sep 11
Langone's portfolio ranking favors Eli Lilly over Home Depot.Wed 23:43

Coverage

Newest first; wire copies grouped

Jul 18ZacksBrokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a sto
Jul 2Unknown outlet